Tag: Atai Life Sciences - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit

atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro Summit

Post published:October 6, 2023
Post category:Press Release

Read more about the article atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants

atai Life Sciences Announces Completion of Phase 1 Study of VLS-01 in Healthy Participants

Post published:October 3, 2023
Post category:Press Release

Read more about the article atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

atai Life Sciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

Post published:September 14, 2023
Post category:Press Release

Read more about the article atai Life Sciences to Participate in Upcoming September Investor Conferences

atai Life Sciences to Participate in Upcoming September Investor Conferences

Post published:September 6, 2023
Post category:Press Release

Read more about the article atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)

atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine)

Post published:August 10, 2023
Post category:Press Release

Read more about the article atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)

atai Life Sciences Announces Results from the Phase 1 IV-to-Subcutaneous Bridging Study of PCN-101 (R-Ketamine)

Post published:August 8, 2023
Post category:Press Release

Read more about the article atai Life Sciences to Participate in Upcoming June Investor Conferences

atai Life Sciences to Participate in Upcoming June Investor Conferences

Post published:June 1, 2023
Post category:Press Release

Read more about the article atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates

atai Life Sciences Reports First Quarter 2023 Financial Results and Announces Pipeline Highlights and Updates

Post published:May 11, 2023
Post category:Press Release

Read more about the article atai Life Sciences to Participate in Upcoming May Investor Conference

atai Life Sciences to Participate in Upcoming May Investor Conference

Post published:May 3, 2023
Post category:Press Release

Read more about the article atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late Breaking Poster Presentation at the 2023 SOBP Annual Meeting

atai Life Sciences Presents Pharmacodynamic Data on GRX-917 in a Late Breaking Poster Presentation at the 2023 SOBP Annual Meeting

Post published:April 28, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.